Table 2.

Antibiotic susceptibility of W. confusa in previous reports

Antibiotic	Susceptible isolates/total no. of isolates	References
Aminoglycosides (gentamicin)	2/2	[8, 17]
Amphenicols (chloramphenicol)	2/2	[8, 17]
Antifolates (trimethoprim-sulfamethoxazole)	1/5	[4, 6, 8, 17, 25]
Carbapenems (imipenem)	2/2	[17, 25]
Cephalosporins (cephalothin, cefotaxime, cefoxitin, ceftazidime, ceftobiprole, ceftriaxone, cefuroxime)	7/14	[4, 6, 12, 17, 24, 25]
Cyclic lipopeptides (daptomycin)	4/4	[5, 7, 8, 12]
Glycopeptides (teicoplanin, vancomycin)	9/10	[4, 7–9, 12, 17, 24, 25]
Lincosamides (clindamycin)	5/5	[4, 8, 12, 24, 25]
Macrolides (erythromycin)	6/6	[4, 8, 12, 17, 24, 25]
Nitroimidazoles (metronidazole)	0/2	[7, 25]
Oxazolidinones (linezolid)	2/2	[6, 8]
Quinolones (ciprofloxacin, levofloxacin, moxifloxacin)	7/9	[4, 7, 8, 17, 24, 25]
Penicillins (amoxicillin, amoxicillin-clavulanate, ampicillin, piperacillin/tazobactam)	10/12*	[4, 8, 12, 17, 24, 25]
Rifamycins (rifampicin)	0/2	[7, 17]
Tetracyclines (tetracycline, tigecycline)	6/6	[4, 6–8, 12]

*One isolate showed intermediate sensitivity.